Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 255  Show
  1. 1
    "Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1."
    Abe T., Kakyo M., Tokui T., Nakagomi R., Nishio T., Nakai D., Nomura H., Unno M., Suzuki M., Naitoh T., Matsuno S., Yawo H.
    J. Biol. Chem. 274:17159-17163(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, VARIANTS LYS-152 AND ASN-241.
    Category: Function, Expression, Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters."
    Hsiang B.H., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.-P., Kirchgessner T.G.
    J. Biol. Chem. 274:37161-37168(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, VARIANT ASP-130.
    Category: Function, Expression, Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    "A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane."
    Koenig J., Cui Y., Nies A.T., Keppler D.
    Am. J. Physiol. 278:G156-G164(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    Nezu J.
    Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).
  5. 5
    "Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide."
    Koenig J., Cui Y., Nies A.T., Keppler D.
    J. Biol. Chem. 275:23161-23168(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  6. 6
    SeattleSNPs variation discovery resource
    Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ASP-130.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  7. 7
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Mammary gland.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12919 other entries.

  8. 8
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS ASP-130 AND THR-155.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50495 other entries.

  10. 10
    "Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver."
    van de Steeg E., Stranecky V., Hartmannova H., Noskova L., Hrebicek M., Wagenaar E., van Esch A., de Waart D.R., Oude Elferink R.P., Kenworthy K.E., Sticova E., al-Edreesi M., Knisely A.S., Kmoch S., Jirsa M., Schinkel A.H.
    J. Clin. Invest. 122:519-528(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, TISSUE SPECIFICITY, INVOLVEMENT IN HBLRR.
    Category: Function, Pathology & Biotech, Expression.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 23 other entries.

  11. 11
    "N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1."
    Yao J., Hong W., Huang J., Zhan K., Huang H., Hong M.
    PLoS ONE 7:E52563-E52563(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION AT ASN-134; ASN-503 AND ASN-516.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 7 other entries.

  12. 12
    "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
    Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.
    J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-295; SER-672 AND SER-682, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 11200 other entries.

  13. 13
    "Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans."
    Tirona R.G., Leake B.F., Merino G., Kim R.B.
    J. Biol. Chem. 276:35669-35675(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS LEU-73; ALA-82; ASP-130; LYS-152; THR-155; GLY-156; ALA-174; ASN-241; THR-353; ASP-432; GLY-462; ALA-488; GLY-655 AND GLY-667, CHARACTERIZATION.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 7 other entries.

  14. 14
    "A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter."
    Michalski C., Cui Y., Nies A.T., Nuessler A.K., Neuhaus P., Zanger U.M., Klein K., Eichelbaum M., Keppler D., Koenig J.
    J. Biol. Chem. 277:43058-43063(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: CHARACTERIZATION OF VARIANTS ASP-130; THR-155 AND ARG-193, FUNCTION, SUBCELLULAR LOCATION.
    Category: Function, Subcellular Location, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 7 other entries.

  15. 15
    "Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis."
    Nozawa T., Nakajima M., Tamai I., Noda K., Nezu J., Sai Y., Tsuji A., Yokoi T.
    J. Pharmacol. Exp. Ther. 302:804-813(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS ASP-130; LYS-152; ALA-174 AND ASN-241.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 16 other entries.

  16. 16
    "Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha."
    Jung D., Hagenbuch B., Gresh L., Pontoglio M., Meier P.J., Kullak-Ublick G.A.
    J. Biol. Chem. 276:37206-37214(2001) [PubMed] [Europe PMC] [Abstract]
    Annotation: The promoter of SLC21A6 gene was characterized and regulated by HNF 1alpha.Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  17. 17
    "Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation."
    Tirona R.G., Leake B.F., Wolkoff A.W., Kim R.B.
    J. Pharmacol. Exp. Ther. 304:223-228(2003) [PubMed] [Europe PMC] [Abstract]
    Annotation: human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activationImported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  18. 18
    "The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport."
    Wang P., Kim R.B., Chowdhury J.R., Wolkoff A.W.
    J. Biol. Chem. 278:20695-20699(2003) [PubMed] [Europe PMC] [Abstract]
    Annotation: a role for OATP2 in hepatocyte bilirubin transport is unlikelyImported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  19. 19
    "Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics."
    Nishizato Y., Ieiri I., Suzuki H., Kimura M., Kawabata K., Hirota T., Takane H., Irie S., Kusuhara H., Urasaki Y., Urae A., Higuchi S., Otsubo K., Sugiyama Y.
    Clin. Pharmacol. Ther. 73:554-565(2003) [PubMed] [Europe PMC] [Abstract]
    Annotation: commonly occurring single-nucleotide polymorphisms in OATP-C such as T521C (Val174Ala) are likely to be associated with altered pharmacokinetics of pravastatin; Clinical trial of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 11 other entries.

  20. 20
    "Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics."
    Mwinyi J., Johne A., Bauer S., Roots I., Gerloff T.
    Clin. Pharmacol. Ther. 75:415-421(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  21. 21
    "High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)."
    Niemi M., Schaeffeler E., Lang T., Fromm M.F., Neuvonen M., Kyrklund C., Backman J.T., Kerb R., Schwab M., Neuvonen P.J., Eichelbaum M., Kivisto K.T.
    Pharmacogenetics 14:429-440(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: In heterozygous carriers the pharmacokinetics of pravastatin were higher compared to non-carriers; Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 34 other entries.

  22. 22
    "Risk factors for severe hyperbilirubinemia in neonates."
    Huang M.J., Kua K.E., Teng H.C., Tang K.S., Weng H.W., Huang C.S.
    Pediatr. Res. 56:682-689(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: neonates who carry the 211 and 388 variants in the UGT1A1 and OATP 2 genes respectively as well as feed with breast milk are at high risk to develop severe hyperbilirubinemia.Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  23. 23
    "Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects."
    Ieiri I., Suzuki H., Kimura M., Takane H., Nishizato Y., Irie S., Urae A., Kawabata K., Higuchi S., Otsubo K., Sugiyama Y.
    Hepatol. Res. 30:91-95(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-disease association. (HuGE Navigator)Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 32 other entries.

  24. 24
    "Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia."
    Campbell S.D., de Morais S.M., Xu J.J.
    Chem. Biol. Interact. 150:179-187(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: Inhibition of OATP1B1 is an important mechanism for drug-induced unconjugated hyperbilirubinemia.Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

  25. 25
    "Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors."
    Tachibana-Iimori R., Tabara Y., Kusuhara H., Kohara K., Kawamoto R., Nakura J., Tokunaga K., Kondo I., Sugiyama Y., Miki T.
    Drug Metab. Pharmacokinet. 19:375-380(2004) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)Imported.
    Source: GeneRIF:10599.

    This publication is mapped to 8 other entries.

1 to 25 of 255  Show